2024 Q2 Form 10-Q Financial Statement

#000103500224000022 Filed on April 25, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $34.49B $31.76B
YoY Change -0.06% -12.84%
Cost Of Revenue $33.05B $29.78B
YoY Change 4.83% -7.33%
Gross Profit $1.439B $1.983B
YoY Change -51.73% -53.96%
Gross Profit Margin 4.17% 6.24%
Selling, General & Admin $203.0M $258.0M
YoY Change -2.87% 5.74%
% of Gross Profit 14.11% 13.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $696.0M $695.0M
YoY Change 4.04% 5.3%
% of Gross Profit 48.37% 35.05%
Operating Expenses $218.0M $304.0M
YoY Change -1.8% 15.15%
Operating Profit $1.221B $1.679B
YoY Change -55.74% -58.47%
Interest Expense $140.0M -$140.0M
YoY Change -262.79% -195.89%
% of Operating Profit 11.47% -8.34%
Other Income/Expense, Net $122.0M $144.0M
YoY Change 177.27% 11.63%
Pretax Income $1.203B $1.683B
YoY Change -55.72% -58.2%
Income Tax $277.0M $353.0M
% Of Pretax Income 23.03% 20.97%
Net Earnings $880.0M $1.242B
YoY Change -54.59% -59.5%
Net Earnings / Revenue 2.55% 3.91%
Basic Earnings Per Share $2.71 $3.75
Diluted Earnings Per Share $2.71 $3.75
COMMON SHARES
Basic Shares Outstanding 327.0M shares 332.5M shares
Diluted Shares Outstanding 324.0M shares 331.0M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.246B $4.917B
YoY Change 3.37% -10.94%
Cash & Equivalents $5.246B $4.917B
Short-Term Investments
Other Short-Term Assets $696.0M $695.0M
YoY Change -9.73% 3.58%
Inventory $8.028B $7.912B
Prepaid Expenses
Receivables $13.15B $12.15B
Other Receivables $0.00 $0.00
Total Short-Term Assets $27.12B $25.67B
YoY Change 14.43% 10.02%
LONG-TERM ASSETS
Property, Plant & Equipment $29.77B $30.07B
YoY Change -2.62% -2.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $6.731B $6.828B
YoY Change 5.14% 12.64%
Total Long-Term Assets $36.50B $36.90B
YoY Change -1.28% 0.16%
TOTAL ASSETS
Total Short-Term Assets $27.12B $25.67B
Total Long-Term Assets $36.50B $36.90B
Total Assets $63.62B $62.57B
YoY Change 4.86% 3.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.57B $12.46B
YoY Change 34.55% 18.67%
Accrued Expenses $1.065B $2.416B
YoY Change -57.79% 106.85%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $995.0M $853.0M
YoY Change -16.6% -32.19%
Total Short-Term Liabilities $18.32B $16.15B
YoY Change 22.54% 5.1%
LONG-TERM LIABILITIES
Long-Term Debt $9.746B $10.04B
YoY Change -3.79% -1.27%
Other Long-Term Liabilities $2.077B $2.297B
YoY Change -6.15% 0.22%
Total Long-Term Liabilities $2.077B $12.34B
YoY Change -83.17% 438.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.32B $16.15B
Total Long-Term Liabilities $2.077B $12.34B
Total Liabilities $20.40B $36.52B
YoY Change -41.42% 106.81%
SHAREHOLDERS EQUITY
Retained Earnings $47.05B $46.52B
YoY Change 10.68% 13.64%
Common Stock $6.936B $6.923B
YoY Change 0.58% 0.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $25.44B $26.06B
YoY Change
Total Liabilities & Shareholders Equity $63.62B $62.57B
YoY Change 4.86% 3.98%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $880.0M $1.242B
YoY Change -54.59% -59.5%
Depreciation, Depletion And Amortization $696.0M $695.0M
YoY Change 4.04% 5.3%
Cash From Operating Activities $2.472B $1.846B
YoY Change 63.49% -41.77%
INVESTING ACTIVITIES
Capital Expenditures $194.0M $200.0M
YoY Change 14.12% -24.53%
Acquisitions
YoY Change
Other Investing Activities -$198.0M -$437.0M
YoY Change -44.85% 10825.0%
Cash From Investing Activities -$392.0M -$637.0M
YoY Change -25.9% 16.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.547B -1.644B
YoY Change 1.64% -17.72%
NET CHANGE
Cash From Operating Activities 2.472B 1.846B
Cash From Investing Activities -392.0M -637.0M
Cash From Financing Activities -1.547B -1.644B
Net Change In Cash 533.0M -435.0M
YoY Change -198.89% -166.01%
FREE CASH FLOW
Cash From Operating Activities $2.472B $1.846B
Capital Expenditures $194.0M $200.0M
Free Cash Flow $2.278B $1.646B
YoY Change 69.75% -43.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Cost Direct Material
CostDirectMaterial
27682000000 usd
CY2023Q1 us-gaap Cost Direct Material
CostDirectMaterial
30005000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1411000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1477000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
683000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
650000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
29776000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
32132000000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
34000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
258000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1679000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4043000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
144000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
129000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
140000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
146000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1683000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4026000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
353000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
880000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1330000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3146000000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
85000000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
79000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1245000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3067000000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.75
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.30
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369000000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.75
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.29
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
331000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
369000000 shares
CY2024Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1387000000 usd
CY2023Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
1422000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1330000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3146000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
-153000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
134000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
6000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
7000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
-84000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
57000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-243000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
184000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-15000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
1000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-228000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
183000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1102000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3329000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
42000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
108000000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1060000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3221000000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28524000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1330000000 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.07
CY2024Q1 us-gaap Dividends
Dividends
356000000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 usd
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1033000000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
90000000 usd
CY2024Q1 vlo Noncontrolling Interest Increase From Debt To Equity Conversion
NoncontrollingInterestIncreaseFromDebtToEquityConversion
457000000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-228000000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28824000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
25468000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3146000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.02
CY2023Q1 us-gaap Dividends
Dividends
379000000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1466000000 usd
CY2023Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
75000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
183000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27067000000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
1330000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
3146000000 usd
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
695000000 usd
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
660000000 usd
CY2024Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
11000000 usd
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-69000000 usd
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
54000000 usd
CY2024Q1 vlo Increase Decrease In Operating Capital Current
IncreaseDecreaseInOperatingCapitalCurrent
160000000 usd
CY2023Q1 vlo Increase Decrease In Operating Capital Current
IncreaseDecreaseInOperatingCapitalCurrent
534000000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-50000000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
145000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1846000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3170000000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
11000000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
100000000 usd
CY2024Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
33000000 usd
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
71000000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-2000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-4000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-637000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-549000000 usd
CY2024Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
CY2023Q1 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
5000000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1023000000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1451000000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
356000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
379000000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
90000000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
75000000 usd
CY2024Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1644000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1998000000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-72000000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-507000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
659000000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5424000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4862000000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4917000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5521000000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="padding-left:18pt"><span style="color:#0070ab;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the amounts reported in these interim unaudited financial statements and accompanying notes. Actual results could differ from those estimates. On an ongoing basis, we review our estimates based on currently available information. Changes in facts and circumstances may result in revised estimates.</span></div>
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="padding-left:18pt;text-indent:-18pt"><span style="color:#0070ab;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.    UNCERTAINTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In September 2022, California adopted Senate Bill No. 1322 (SB 1322), which requires refineries in California to report monthly on the volume and cost of the crude oil they buy, the quantity and price of the wholesale gasoline they sell, and the gross gasoline margin per barrel, among other information. The provisions of SB 1322 were effective January 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In March 2023, California adopted Senate Bill No. 2 (such statute, together with any regulations contemplated or issued thereunder, SBx 1-2), which, among other things, (i) authorized the establishment of a maximum gross gasoline refining margin (max margin) and the imposition of a financial penalty for profits above a max margin, (ii) significantly expanded the reporting obligations under SB 1322 and the Petroleum Industry Information Reporting Act of 1980, which include reporting requirements to the California Energy Commission (CEC) for all participants in the petroleum industry supply chain in California (e.g., refiners, marketers, importers, transporters, terminals, producers, renewables producers, pipelines, and ports), (iii) created the Division of Petroleum Market Oversight within the CEC to analyze the data provided under SBx 1-2, and (iv) authorized the CEC to regulate the timing and other aspects of refinery turnaround and maintenance activities in certain instances. SBx 1-2 imposes increased and substantial reporting requirements, which include daily, weekly, monthly, and annual reporting of detailed operational and financial data on all aspects of our operations in California, much of it at the transaction level. The operational data includes our plans for turnaround and maintenance activities at our two California refineries and the manner in which we expect to address the potential impacts on feedstock and product inventories in California as a result of such turnaround and maintenance activities. The provisions of SBx 1-2 became effective June 26, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In September 2023, Governor Newsom directed the CEC to immediately begin the regulatory processes concerning the potential imposition of a penalty for exceeding a max margin and the timing of refinery turnarounds and maintenance. Consequently, in October 2023, the CEC adopted an order instituting an informational proceeding on a max margin and penalty under SBx 1-2, as well as an order initiating rulemaking activity under SBx 1-2. The CEC indicated in a November 2023 workshop that the latter rulemaking process will be focused on rules relating to the timing of refinery maintenance and turnarounds, as well as the standardization of data collection and reporting. It remains uncertain as to what extent any regulations will address the remaining reporting requirements under SBx 1-2.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We continue to review and analyze the provisions of SBx 1-2 and the possible impacts to our refining and marketing operations in California. While the CEC has not yet established a max margin, imposed a financial penalty for profits above a max margin, or imposed restrictions on turnaround and maintenance </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">activities, the potential implementation of a financial penalty or of any restrictions or delays on our ability to undertake turnaround or maintenance activities creates uncertainty due to the potential adverse effects on us. Any adverse effects on our operations or financial performance in California could indicate that the carrying value of our assets in California is not recoverable, which would result in an impairment loss that could be material. In addition, if the circumstances that trigger an impairment loss result in a reduction in the estimated useful lives of the assets, we may be required to recognize an asset retirement obligation that could be material. Other jurisdictions are contemplating similarly focused legislation or actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The ultimate timing and impacts of SBx 1-2 and any other similarly focused legislation or actions are subject to considerable uncertainty due to a number of factors, including technological and economic feasibility, legal challenges, and potential changes in law, regulation, or policy, and it is not currently possible to predict the ultimate effects of these matters and developments on our financial condition, results of operations, and liquidity.</span></div>
CY2024Q1 us-gaap Crude Oil And Natural Gas Liquids
CrudeOilAndNaturalGasLiquids
2366000000 usd
CY2023Q4 us-gaap Crude Oil And Natural Gas Liquids
CrudeOilAndNaturalGasLiquids
2223000000 usd
CY2024Q1 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
3847000000 usd
CY2023Q4 us-gaap Inventory Crude Oil Products And Merchandise
InventoryCrudeOilProductsAndMerchandise
3790000000 usd
CY2024Q1 vlo Renewable Diesel Feedstocks And Products
RenewableDieselFeedstocksAndProducts
1051000000 usd
CY2023Q4 vlo Renewable Diesel Feedstocks And Products
RenewableDieselFeedstocksAndProducts
913000000 usd
CY2024Q1 vlo Ethanol Feedstocks And Products
EthanolFeedstocksAndProducts
300000000 usd
CY2023Q4 vlo Ethanol Feedstocks And Products
EthanolFeedstocksAndProducts
313000000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
348000000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
344000000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
7912000000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7583000000 usd
CY2024Q1 us-gaap Excess Of Replacement Or Current Costs Over Stated Lifo Value
ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
6000000000 usd
CY2023Q4 us-gaap Excess Of Replacement Or Current Costs Over Stated Lifo Value
ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
4400000000 usd
CY2024Q1 us-gaap Weighted Average Cost Inventory Amount
WeightedAverageCostInventoryAmount
1300000000 usd
CY2023Q4 us-gaap Weighted Average Cost Inventory Amount
WeightedAverageCostInventoryAmount
1500000000 usd
CY2024Q1 vlo Noncontrolling Interest Increase From Debt To Equity Conversion
NoncontrollingInterestIncreaseFromDebtToEquityConversion
457000000 usd
CY2024Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
147000000 usd
CY2023Q1 us-gaap Interest Costs Incurred
InterestCostsIncurred
152000000 usd
CY2024Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
7000000 usd
CY2023Q1 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
6000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
140000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
146000000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1245000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3067000000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
3000000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
10000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1242000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3057000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369000000 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.75
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.30
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1245000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
3067000000 usd
CY2024Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
3000000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
10000000 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1242000000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
3057000000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
369000000 shares
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
331000000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
369000000 shares
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.75
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
8.29
CY2024Q1 us-gaap Contract With Customer Receivable Before Allowance For Credit Loss Current
ContractWithCustomerReceivableBeforeAllowanceForCreditLossCurrent
6788000000 usd
CY2023Q4 us-gaap Contract With Customer Receivable Before Allowance For Credit Loss Current
ContractWithCustomerReceivableBeforeAllowanceForCreditLossCurrent
7209000000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34000000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40000000 usd
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31759000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31759000000 usd
CY2024Q1 us-gaap Cost Direct Material
CostDirectMaterial
27682000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1411000000 usd
CY2024Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
683000000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
29776000000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
34000000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
258000000 usd
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12000000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1679000000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
144000000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
140000000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1683000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36439000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36439000000 usd
CY2023Q1 us-gaap Cost Direct Material
CostDirectMaterial
30005000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1477000000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
650000000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
32132000000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
10000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
244000000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
4043000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
129000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
146000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4026000000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31759000000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36439000000 usd
CY2024Q1 us-gaap Assets
Assets
62574000000 usd
CY2023Q4 us-gaap Assets
Assets
63056000000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-257000000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2381000000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
356000000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
641000000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-86000000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
37000000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-130000000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2269000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-163000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-61000000 usd
CY2024Q1 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-102000000 usd
CY2023Q1 us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-23000000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
248000000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
116000000 usd
CY2024Q1 vlo Increase Decrease In Operating Capital Current
IncreaseDecreaseInOperatingCapitalCurrent
160000000 usd
CY2023Q1 vlo Increase Decrease In Operating Capital Current
IncreaseDecreaseInOperatingCapitalCurrent
534000000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
100000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
82000000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
103000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
616000000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
124000000 usd
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
29000000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
102000000 usd
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
27000000 usd
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
56000000 usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
49000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
153000000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
186000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
67000000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
47000000 usd
CY2024Q1 vlo Noncontrolling Interest Increase From Debt To Equity Conversion
NoncontrollingInterestIncreaseFromDebtToEquityConversion
457000000 usd
CY2024Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
8461000000 usd
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
9218000000 usd
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
We do not require any collateral or other security to support derivative instruments into which we enter.
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001035002-24-000022-index-headers.html Edgar Link pending
0001035002-24-000022-index.html Edgar Link pending
0001035002-24-000022.txt Edgar Link pending
0001035002-24-000022-xbrl.zip Edgar Link pending
a3312024exh3101.htm Edgar Link pending
a3312024exh3102.htm Edgar Link pending
a3312024exh3201.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vlo-20240331.htm Edgar Link pending
vlo-20240331.xsd Edgar Link pending
vlo-20240331_g1.jpg Edgar Link pending
vlo-20240331_htm.xml Edgar Link completed
vlo-20240331_cal.xml Edgar Link unprocessable
vlo-20240331_def.xml Edgar Link unprocessable
vlo-20240331_lab.xml Edgar Link unprocessable
vlo-20240331_pre.xml Edgar Link unprocessable